Estados financieros detallados de Edesa Biotech, Inc. (EDSA): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $3.87, EDSA presenta beneficios negativos (P/E no significativo) y un ROE del -124.21%. La capitalización bursátil es de $37M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $1.3M | $228287 | $211849 | $410870 | $328801 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $1.1M | $534453 | $445320 | $101286 | $17601 | $118788 | 0 | 0 | 0 | $119273 |
| Beneficio Bruto | $143861 | -$306166 | -$233471 | $309584 | $311200 | -$118788 | 0 | 0 | 0 | -$119273 |
| I+D | $1.7M | $2.0M | $2.1M | $1.1M | $3.3M | $17.9M | $13.3M | $4.8M | $2.9M | $3.7M |
| Generales y Administrativos | $3.3M | $2.9M | $2.8M | $2.0M | $3.4M | $5.7M | $5.0M | $4.4M | $4.1M | $4.2M |
| Gastos Operativos | $5.1M | $4.9M | $4.8M | $3.1M | $6.7M | $23.7M | $18.4M | $9.2M | $7.0M | $7.8M |
| Beneficio Operativo | -$4.9M | -$5.2M | -$5.1M | -$2.8M | -$6.4M | -$23.7M | -$18.4M | -$9.2M | -$7.0M | -$7.9M |
| EBITDA | -$4.9M | -$4.9M | -$4.8M | -$2.8M | -$6.3M | -$13.2M | -$17.5M | -$8.5M | -$6.1M | -$7.1M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$5.0M | -$5.0M | -$5.0M | -$2.8M | -$6.4M | -$13.3M | -$17.5M | -$8.4M | -$6.2M | -$7.2M |
| Impuestos | $7200 | $800 | $800 | -$55404 | $800 | $800 | $800 | $800 | $800 | $800 |
| Beneficio Neto | -$5.0M | -$5.0M | -$5.0M | -$2.7M | -$6.4M | -$13.3M | -$17.5M | -$8.4M | -$6.2M | -$7.2M |
| BPA | $-23.92 | $-36.78 | $-3.32 | $-4.79 | $-5.18 | $-7.73 | $-8.37 | $-2.93 | $-1.93 | $-1.27 |
| BPA Diluido | $-23.92 | $-36.78 | $-3.32 | $-4.79 | $-5.18 | $-7.73 | $-8.37 | $-2.93 | $-1.93 | $-1.27 |
| Acciones en Circulación (Diluidas) | $210150 | $23810 | $462843 | $655318 | $1.2M | $1.7M | $2.1M | $2.9M | $3.2M | $5.7M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$25868 | -$25459 | -$25872 | -$25644 |
| Beneficio Operativo | -$2.5M | -$2.3M | -$4.3M | -$5.5M |
| EBITDA | -$2.2M | -$2.3M | -$4.3M | -$5.5M |
| Beneficio Neto | -$2.2M | -$2.2M | -$4.2M | -$5.4M |
| BPA | $-0.32 | $-0.28 | $-0.49 | $-0.60 |
| BPA Diluido | $-0.32 | $-0.28 | $-0.49 | $-0.60 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $7.4M | $4.6M | $4.2M | $5.0M | $7.2M | $7.8M | $7.1M | $5.4M | $1.0M | $10.8M |
| Inversiones a Corto | $4.0M | $2.0M | $6.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $85813 | $1287 | $41246 | $217101 | $87446 | $3.3M | $1.3M | $626543 | $270908 | $642866 |
| Inventario | $249430 | $68114 | $224267 | -$217101 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $12.1M | $6.8M | $10.7M | $5.6M | $8.1M | $12.1M | $9.1M | $6.4M | $1.7M | $11.5M |
| Inmovilizado Material | $756114 | $879523 | $1.1M | $73058 | $174821 | $111560 | $31159 | $100075 | $18361 | 0 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | $2.5M | $2.4M | $2.3M | $2.2M | $2.1M | $2.0M |
| Activos Totales | $12.9M | $7.7M | $11.8M | $5.7M | $10.8M | $14.6M | $11.6M | $8.9M | $3.8M | $13.5M |
| Cuentas por Pagar | $623644 | $320947 | $493385 | $424634 | $1.5M | $1.4M | $2.1M | $1.7M | 0 | 0 |
| Deuda a Corto | 0 | 0 | 0 | 0 | $69730 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $623644 | $320947 | $493385 | $461634 | $1.5M | $1.5M | $2.1M | $1.8M | $1.8M | $1.1M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $623644 | $320947 | $493385 | $461634 | $1.7M | $1.5M | $2.2M | $1.8M | $1.8M | $1.1M |
| Reservas | -$40.4M | -$45.4M | -$50.4M | -$6.7M | -$13.1M | -$26.5M | -$44.0M | -$52.4M | -$58.6M | -$65.9M |
| Patrimonio Neto | $12.3M | $7.4M | $11.3M | $5.3M | $9.1M | $13.1M | $9.4M | $7.0M | $2.0M | $12.5M |
| Deuda Total | 0 | 0 | 0 | 0 | $164189 | $99320 | $18975 | $94487 | $19867 | 0 |
| Deuda Neta | -$11.4M | -$6.6M | -$10.3M | -$5.0M | -$7.0M | -$7.7M | -$7.1M | -$5.3M | -$1.0M | -$10.8M |
| Capital Circulante | $11.5M | $6.4M | $10.2M | $5.2M | $6.6M | $10.6M | $7.0M | $4.6M | -$157205 | $10.4M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $10.8M | $12.1M | $10.0M | $10.3M |
| Activos Totales | $13.7M | $14.7M | $12.4M | $12.7M |
| Pasivos Totales | $1.2M | $756163 | $2.2M | $3.9M |
| Patrimonio Neto | $12.5M | $14.0M | $10.2M | $8.8M |
| Deuda Total | 0 | 0 | 0 | 0 |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$5.0M | -$5.0M | -$5.0M | -$2.8M | -$6.4M | -$13.3M | -$17.5M | -$8.4M | -$6.2M | -$7.2M |
| Amortizaciones | $149565 | $179322 | $188372 | $4779 | $57563 | $118788 | $118188 | $183471 | $186049 | $119273 |
| Compensación en Acciones | $259379 | $115546 | $154313 | $46508 | $598359 | $3.2M | $2.3M | $1.2M | $537492 | $729642 |
| Cambio en Capital Circulante | -$23649 | $198159 | $13042 | -$2.1M | $721968 | -$3.6M | $2.9M | $308004 | $571065 | -$985654 |
| Flujo de Caja Operativo | -$4.5M | -$4.7M | -$4.6M | -$4.8M | -$5.0M | -$13.7M | -$12.3M | -$6.6M | -$4.9M | -$7.3M |
| Inversiones (CapEx) | -$402271 | -$302733 | -$382810 | -$8095 | -$34339 | -$6146 | -$5656 | $3 | 0 | 0 |
| Adquisiciones | -$66695 | 0 | 0 | $6.4M | $29483 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$4.9M | -$5.0M | -$5.0M | -$4.9M | -$5.0M | -$13.7M | -$12.3M | -$6.6M | -$4.9M | -$7.3M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$1.8M | -$2.1M | -$2.1M | -$3.0M |
| Inversiones (CapEx) | $3 | $4 | $3 | -$7 |
| Flujo de Caja Libre | -$1.8M | -$2.1M | -$2.1M | -$3.0M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $404425 | $81183 | $66653 | -$147836 |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | -82.0% | -7.2% | +93.9% | -20.0% | -100.0% | | | | |
| Crecimiento Beneficio Neto (anual) | | -0.1% | -0.2% | +46.0% | -133.9% | -109.7% | -31.5% | +52.3% | +26.3% | -16.5% |
| Crecimiento BPA (anual) | | -53.8% | +91.0% | -44.3% | -8.1% | -49.2% | -8.3% | +65.0% | +34.1% | +34.2% |
| Cambio en Acciones (anual) | | -88.7% | +1843.9% | +41.6% | +87.6% | +40.3% | +21.5% | +36.4% | +11.8% | +77.5% |
| Crecimiento FCF (anual) | | -1.9% | +0.1% | +2.9% | -3.4% | -172.3% | +10.1% | +46.0% | +26.3% | -49.7% |
| Margen Bruto | 11.3% | -134.1% | -110.2% | 75.3% | 94.6% | | | | | |
| Margen Operativo | -386.0% | -2288.6% | -2397.1% | -689.3% | -1946.7% | | | | | |
| Margen EBITDA | -382.9% | -2124.7% | -2289.3% | -688.1% | -1929.8% | | | | | |
| Margen Neto | -395.2% | -2203.7% | -2378.6% | -662.3% | -1935.6% | | | | | |
| Margen FCF | -385.9% | -2191.3% | -2359.4% | -1181.4% | -1527.0% | | | | | |
| Tasa Impositiva Efectiva | -0.1% | -0.0% | -0.0% | 2.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-23.35 | $-210.10 | $-10.80 | $-7.41 | $-4.08 | $-7.92 | $-5.86 | $-2.32 | $-1.53 | $-1.29 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $210150 | $23000 | $462000 | $655000 | $1.2M | $1.7M | $2.1M | $2.9M | $3.2M | $5.7M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -124.21% |
| Rentabilidad sobre capital invertido | -166.02% |
| Rentabilidad sobre activos | -110.85% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 2.76 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -29.50 | -9.03 | -17.58 | -9.10 | -10.91 | -6.68 | -0.77 | -1.51 | -2.31 | -1.94 |
| P/VC | 12.04 | 1.03 | 2.39 | 5.43 | 7.62 | 6.82 | 1.44 | 1.79 | 7.18 | 1.13 |
| P/V | 116.60 | 33.47 | 127.32 | 69.52 | 211.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 11.3% | -134.1% | -110.2% | 75.3% | 94.6% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | -386.0% | -2288.6% | -2397.1% | -689.3% | -1946.7% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | -395.2% | -2203.7% | -2378.6% | -662.3% | -1935.6% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |